SOBR Safe Expands Global Intellectual Patent Portfolio with Issuance of European Patent
SOBR Safe (NASDAQ:SOBR) has secured a significant European Patent (EP4171362) for its SOBRcheck鈩� device, strengthening its intellectual property portfolio in alcohol monitoring technology. The patent, granted by the European Patent Office on July 10, 2025, covers the company's non-invasive transdermal alcohol screening system.
The patented technology combines transdermal alcohol sensors with biometric identification, featuring skin contact verification and environmental compensation for accurate readings. The system can store, analyze, and wirelessly transmit data in real-time. SOBRsafe plans to commence pilot tests in Europe in the second half of 2025, marking a significant step in its international expansion strategy.
SOBR Safe (NASDAQ:SOBR) ha ottenuto un importante brevetto europeo (EP4171362) per il suo dispositivo SOBRcheck鈩�, rafforzando il proprio portafoglio di propriet脿 intellettuale nella tecnologia di monitoraggio dell'alcol. Il brevetto, concesso dall'Ufficio Europeo dei Brevetti il 10 luglio 2025, riguarda il sistema non invasivo di screening dell'alcol transdermico dell'azienda.
La tecnologia brevettata combina sensori transdermici per l'alcol con l'identificazione biometrica, includendo la verifica del contatto cutaneo e la compensazione ambientale per letture precise. Il sistema 猫 in grado di memorizzare, analizzare e trasmettere dati in tempo reale in modalit脿 wireless. SOBR Safe prevede di avviare test pilota in Europa nella seconda met脿 del 2025, rappresentando un passo importante nella sua strategia di espansione internazionale.
SOBR Safe (NASDAQ:SOBR) ha asegurado una patente europea significativa (EP4171362) para su dispositivo SOBRcheck鈩�, fortaleciendo su cartera de propiedad intelectual en tecnolog铆a de monitoreo de alcohol. La patente, otorgada por la Oficina Europea de Patentes el 10 de julio de 2025, cubre el sistema no invasivo de detecci贸n transd茅rmica de alcohol de la compa帽铆a.
La tecnolog铆a patentada combina sensores transd茅rmicos de alcohol con identificaci贸n biom茅trica, incluyendo verificaci贸n de contacto con la piel y compensaci贸n ambiental para lecturas precisas. El sistema puede almacenar, analizar y transmitir datos inal谩mbricamente en tiempo real. SOBR Safe planea iniciar pruebas piloto en Europa en la segunda mitad de 2025, marcando un paso importante en su estrategia de expansi贸n internacional.
SOBR Safe (NASDAQ:SOBR)電� SOBRcheck鈩� 鞛レ箻鞐� 雽�頃� 欷戩殧頃� 鞙犽熃 韸鬼棃(EP4171362)毳� 頇曤炒頃橃棳 鞎岇綌鞓� 氇媹韯半 旮办垹 攵勳暭鞐愳劀 歆�鞝� 鞛偘甓� 韽姼韽措Μ鞓るゼ 臧曧檾頄堨姷雼堧嫟. 鞚� 韸鬼棃電� 2025雲� 7鞗� 10鞚� 鞙犽熃 韸鬼棃觳棎靹� 攵�鞐悩鞐堨溂氅�, 須岇偓鞚� 牍勳龚鞀奠爜 瓴巾敿 鞎岇綌鞓� 瓴�靷� 鞁滌姢韰�鞚� 韽暔頃╇媹雼�.
韸鬼棃 旮办垹鞚� 瓴巾敿 鞎岇綌鞓� 靹检劀鞕� 靸濎泊 鞚胳嫕鞚� 瓴绊暕頃橃棳 頂茧秬 鞝戩磯 頇曥澑瓿� 頇橁步 氤挫爼鞚� 韱淀暣 鞝曧檿頃� 旄§爼鞚� 鞝滉车頃╇媹雼�. 鞚� 鞁滌姢韰滌潃 雿办澊韯半ゼ 鞁れ嫓臧勳溂搿� 鞝�鞛�, 攵勳劃 氚� 氍挫劆 鞝勳啞頃� 靾� 鞛堨姷雼堧嫟. SOBR Safe電� 2025雲� 頃橂皹旮� 鞙犽熃鞐愳劀 韺岇澕霟� 韰岇姢韸鸽ゼ 鞁滌瀾頃� 瓿勴殟鞙茧, 甑牅 頇曥灔 鞝勲灥鞐� 欷戩殧頃� 鞚挫爼響滉皜 霅� 瓴冹瀰雼堧嫟.
SOBR Safe (NASDAQ:SOBR) a obtenu un brevet europ茅en important (EP4171362) pour son dispositif SOBRcheck鈩�, renfor莽ant ainsi son portefeuille de propri茅t茅 intellectuelle dans la technologie de surveillance de l'alcool. Le brevet, accord茅 par l'Office europ茅en des brevets le 10 juillet 2025, couvre le syst猫me de d茅pistage transdermique non invasif de l'alcool de la soci茅t茅.
La technologie brevet茅e combine des capteurs transdermiques d'alcool avec une identification biom茅trique, incluant une v茅rification du contact cutan茅 et une compensation environnementale pour des mesures pr茅cises. Le syst猫me peut stocker, analyser et transmettre les donn茅es sans fil en temps r茅el. SOBR Safe pr茅voit de commencer des tests pilotes en Europe dans la seconde moiti茅 de 2025, marquant une 茅tape importante dans sa strat茅gie d'expansion internationale.
SOBR Safe (NASDAQ:SOBR) hat ein bedeutendes europ盲isches Patent (EP4171362) f眉r sein SOBRcheck鈩�-Ger盲t erhalten und st盲rkt damit sein geistiges Eigentum im Bereich der Alkohol眉berwachungstechnologie. Das Patent, das am 10. Juli 2025 vom Europ盲ischen Patentamt erteilt wurde, umfasst das nicht-invasive transdermale Alkoholscreeningsystem des Unternehmens.
Die patentierte Technologie kombiniert transdermale Alkoholsensoren mit biometrischer Identifikation und verf眉gt 眉ber Hautkontaktverifizierung sowie Umweltkompensation f眉r genaue Messwerte. Das System kann Daten in Echtzeit speichern, analysieren und drahtlos 眉bertragen. SOBR Safe plant, in der zweiten H盲lfte des Jahres 2025 Pilotversuche in Europa zu starten, was einen wichtigen Schritt in seiner internationalen Expansionsstrategie darstellt.
- Secured European Patent for SOBRcheck鈩� device, expanding global IP protection
- Patent covers comprehensive system architecture including tamper-prevention features
- European market expansion potential with pilot tests planned for H2 2025
- None.
Insights
SOBR's new European patent strengthens IP portfolio and creates foundation for European market entry, enhancing competitive position in alcohol monitoring technology.
SOBR Safe has secured a significant intellectual property victory with the issuance of European Patent No. EP4171362 for its SOBRcheck鈩� device. This patent protects the company's non-invasive transdermal alcohol detection technology across European territories, creating a substantial barrier to competition in this region.
The patent's scope is impressively comprehensive, covering the core system architecture that combines transdermal alcohol sensing with biometric identification in a single device. Critically, it also protects the anti-tampering mechanisms through skin contact verification and environmental compensation features that ensure accuracy in real-world conditions. The data transmission and analysis capabilities are also included in the patent protection.
This patent issuance represents a strategic expansion of SOBR's global IP portfolio and creates a foundation for their planned European market entry. With pilot tests scheduled to commence in the second half of 2025, the company is methodically executing an international expansion strategy.
The timing is particularly advantageous as workplace safety regulations continue to evolve globally, and the protected technology offers advantages over traditional breath, blood, or other invasive sampling methods. By establishing this IP foothold in Europe, SOBR has positioned itself for potential licensing opportunities, partnerships, or direct market entry with significant competitive protection.
This patent complements their existing IP assets and strengthens their competitive moat in workplace safety, judicial compliance, and wellness applications 鈥� all sizable market opportunities across European territories.
European Patent Office Grants Patent for the Company's SOBRcheck鈩� Device
DENVER, COLORADO / / August 6, 2025 / SOBR Safe, Inc. (Nasdaq:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, announced today that the European Patent Office ("EPO") has granted a European Patent to SOBR Safe for the Company's SOBRcheck鈩� device. The EPO published European Patent No. EP4171362 titled "NONINVASIVE TRANSDERMAL ALCOHOL SCREENING SYSTEM" on August 6, 2025, after issuing a Decision to Grant the patent application on July 10, 2025.
SOBRsafe's new European Patent covers a variety of its alcohol detection devices, including the Company's passive, non-invasive alcohol monitoring and detection technology that enables the identification of alcohol consumption emitted through perspiration from the skin without the need for breath, blood or other intrusive sampling methods. The European Patent secures the Company's proprietary system architecture, including combining a transdermal alcohol sensor with a biometric identification scanner to provide an alcohol consumption measurement and identification of a user in a singular device with skin contact verification features to prevent tampering, and also evaluates environmental compensators that ensure accurate readings in real world conditions. In addition, the patent covers the device's ability to store, analyze, and wirelessly transmit data for real time or retrospective monitoring. This foundational intellectual property strengthens SOBRsafe's competitive advantage in workplace safety, judicial compliance, and wellness applications across the European market.
With a growing portfolio of proprietary technology, SOBRsafe is focused on expanding its international footprint. The company has a promising pipeline of opportunities with pilot tests in Europe set to commence in the second half of 2025.
"The granting of our European patent for the SOBRcheck鈩� device represents a major milestone in advancing our intellectual property portfolio and global expansion," said SOBRsafe CEO David Gandini. "This patent affirms the uniqueness of our noninvasive alcohol monitoring and detection system and reinforces the significant investments we have made in research and development. Securing this patent strengthens our competitive position for potential expansion into the European market and lays a solid foundation for future partnerships and pilot programs. We remain focused on delivering reliable, rapid alcohol monitoring and detection solutions that improve safety and accountability worldwide."
About SOBRsafe鈩�
Through next-generation alcohol detection technology, we enable trust and empower recovery ... with a human touch. SOBRsafe's advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin - no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides passive, dignified screening and monitoring solutions for the behavioral health, family law and consumer markets, and for licensing and integration. To learn more, visit .
Safe Harbor Statement
Our prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 and the Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this presentation. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. We caution readers not to place undue reliance upon any such forward-looking statements. The Company does not undertake to publicly update or revise forward-looking statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in the Company's filings with the SEC which can be found on the SEC's website at .
Company Contact:
[email protected]
Investor Relations Contact:
Scott Liolios or Taylor Stadeli
Gateway Group
949-574-3860
[email protected]
SOURCE: SOBR Safe, Inc.
View the original on ACCESS Newswire
FAQ
What patent did SOBR Safe (NASDAQ:SOBR) receive from the European Patent Office?
How does SOBR Safe's patented alcohol detection technology work?
When will SOBR Safe begin pilot testing in Europe?
What are the key features of SOBR Safe's patented technology?
What markets is SOBR Safe targeting with its alcohol monitoring technology?
